Clinical Genomics appoints 4 new experts to leadership team

Bridgewater, N.J.-based Clinical Genomics, a biotechnology company focused on colorectal cancer diagnosis, has appointed four new hires to its leadership team.

Advertisement

Here are the four additions:

1. Laurie Huard, now the company’s COO, previously served as the vice president of operations at Helomics, a molecular diagnostics company focused on personalized healthcare.

2. Karol Ford, now the company’s vice president of sales and marketing, previously worked with Progenity, a genetics reference laboratory.

3. Tania Obranovich, PhD, now the company’s vice president of intellectual property, legal affairs and compliance, previously practiced as a partner at an intellectual property firm in Australia.

4. John Alsobrook II, PhD, now the company’s clinical laboratory director, previously served as the chief science officer at DermTech, a molecular diagnostic dermatology company.

Clinical Genomics is gearing up to launch a two-gene circulating tumor DNA blood test for postoperative monitoring of colorectal cancer.

More articles on health IT:
Hays Medical Center upgrades to MEDITECH’s web-based EHR
Dapasoft launches clinical data integration engine Corolar Cloud
AHA launches MACRA implementation tool

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.